Brain, Vol. 123, No. 6, 1238-1246,
June 2000
© 2000 Oxford University Press
ATP in human skin elicits a dose-related pain response which is potentiated under conditions of hyperalgesia
Neuroscience Research Centre, Guy's, King's College and St Thomas' School of Biomedical Sciences, London, UK
Correspondence to:
Sara Hamilton, Neuroscience Research Centre, Guy's, King's College and St Thomas' School of Biomedical Sciences, St Thomas' Campus, Lambeth Palace Road, London SE1 7EH, UK
Despite the considerable interest in the possibility that ATP may function as a peripheral pain mediator, there has been little quantitative study of the pain-producing effects of ATP in humans. Here we have used iontophoresis to deliver ATP to the forearm skin of volunteers who rated the magnitude of the evoked pain on a visual analogue scale. ATP consistently produced a modest burning pain, which began within 20 s of starting iontophoresis and was maintained for several minutes. Persistent iontophoresis of ATP led to desensitization within 12 min but recovery from this was almost complete 1 h later. Different doses of ATP were delivered using different iontophoretic driving currents. Iontophoresis of ATP produced a higher pain rating than saline, indicating that the pain was specifically caused by ATP. The average pain rating for ATP, but not saline, increased with increasing current. Using an 0.8 mA current, subjects reported pain averaging 27.7 ± 2.8 (maximum possible = 100). Iontophoresis of ATP caused an increase in blood flow, as assessed using a laser Doppler flow meter. The increase in blood flow was significantly greater using ATP than saline in both the iontophoresed skin (P < 0.01) and in the surrounding skin, 3 mm outside the iontophoresed area (P < 0.05). The pain produced by ATP was dependent on capsaicin-sensitive sensory neurons, since in skin treated repeatedly with topical capsaicin pain was reduced to less than 25% of that elicited on normal skin (2.1 ± 0.4 compared with 9.3 ± 1.5 on normal skin). Conversely, the pain-producing effects of ATP were greatly potentiated in several models of hyperalgesia. Thus, with acute capsaicin treatment when subjects exhibited touch-evoked hyperalgesia but no ongoing pain, there was a threefold increase in the average pain rating during ATP iontophoresis (22.7 ± 3.1) compared with pre-capsaicin treatment (7.8 ± 2.6). Moreover, ATP iontophoresed into skin 24 h after solar simulated radiation (2 x minimal erythymic dose) resulted in double the pain rating of normal skin, increasing from 15.3 ± 4.1 to 32.7 ± 4.1. The pain response to saline was not significantly altered after UV irradiation at any time-point studied. We conclude that ATP produces pain by activating capsaicin-sensitive nociceptive afferents when applied to skin. The possibility that ATP activates nociceptors indirectly via its degradation products cannot be ruled out. The effects of ATP are dose-dependent and responses desensitize only slowly. In inflammatory conditions, ATP may be a potent activator of nociceptors and an endogenous mediator of pain.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Ambalavanar and D. Dessem Emerging Peripheral Receptor Targets for Deep-tissue Craniofacial Pain Therapies Journal of Dental Research, March 1, 2009; 88(3): 201 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Whitsel, O. V. Favorov, Y. Li, M. Quibrera, and M. Tommerdahl Area 3a Neuron Response to Skin Nociceptor Afferent Drive Cereb Cortex, February 1, 2009; 19(2): 349 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yu and W. C. de Groat Sensitization of pelvic afferent nerves in the in vitro rat urinary bladder-pelvic nerve preparation by purinergic agonists and cyclophosphamide pretreatment Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1146 - F1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Donnelly-Roberts, S. McGaraughty, C.-C. Shieh, P. Honore, and M. F. Jarvis Painful Purinergic Receptors J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 409 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tashiro, K. Okamoto, S. B. Milam, and D. A. Bereiter Differential Effects of Estradiol on Encoding Properties of TMJ Units in Laminae I and V at the Spinomedullary Junction in Female Rats J Neurophysiol, December 1, 2007; 98(6): 3242 - 3253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ren, X. Zou, L. Fang, and Q. Lin Involvement of Peripheral Purinoceptors in Sympathetic Modulation of Capsaicin-Induced Sensitization of Primary Afferent Fibers J Neurophysiol, November 1, 2006; 96(5): 2207 - 2216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Ford, M. Matchett, J. E. Krause, and W. Yu The P2X3 Antagonist P1, P5-Di[inosine-5'] Pentaphosphate Binds to the Desensitized State of the Receptor in Rat Dorsal Root Ganglion Neurons J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 405 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Jones, R. Slater, H. Cadiou, P. McNaughton, and S. B. McMahon Acid-Induced Pain and Its Modulation in Humans J. Neurosci., December 1, 2004; 24(48): 10974 - 10979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Wynn, B. Ma, H. Z. Ruan, and G. Burnstock Purinergic component of mechanosensory transduction is increased in a rat model of colitis Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G647 - G657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. North P2X3 receptors and peripheral pain mechanisms J. Physiol., January 15, 2004; 554(2): 301 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Kennedy, T S Assis, A J Currie, and E G Rowan Crossing the pain barrier: P2 receptors as targets for novel analgesics J. Physiol., December 15, 2003; 553(3): 683 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sawynok Topical and Peripherally Acting Analgesics Pharmacol. Rev., March 1, 2003; 55(1): 1 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Jarvis, E. C. Burgard, S. McGaraughty, P. Honore, K. Lynch, T. J. Brennan, A. Subieta, T. van Biesen, J. Cartmell, B. Bianchi, et al. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat PNAS, December 24, 2002; 99(26): 17179 - 17184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. North Molecular Physiology of P2X Receptors Physiol Rev, October 1, 2002; 82(4): 1013 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-Y. Xu and L.-Y. M. Huang Peripheral Inflammation Sensitizes P2X Receptor-Mediated Responses in Rat Dorsal Root Ganglion Neurons J. Neurosci., January 1, 2002; 22(1): 93 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Chizh and P. Illes P2X Receptors and Nociception Pharmacol. Rev., December 1, 2001; 53(4): 553 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pare, R. Elde, J. E. Mazurkiewicz, A. M. Smith, and F. L. Rice The Meissner Corpuscle Revised: A Multiafferented Mechanoreceptor with Nociceptor Immunochemical Properties J. Neurosci., September 15, 2001; 21(18): 7236 - 7246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vlaskovska, L. Kasakov, W. Rong, P. Bodin, M. Bardini, D. A. Cockayne, A. P. D. W. Ford, and G. Burnstock P2X3 Knock-Out Mice Reveal a Major Sensory Role for Urothelially Released ATP J. Neurosci., August 1, 2001; 21(15): 5670 - 5677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G Hamilton, S. B McMahon, and G. R Lewin Selective activation of nociceptors by P2X receptor agonists in normal and inflamed rat skin J. Physiol., July 15, 2001; 534(2): 437 - 445. [Abstract] [Full Text] [PDF]
|
|